ADC Therapeutics S.A.
USD3.08
-0.09 (-2.84%)
CEO
Ameet Mallik
IPO Date
2020-05-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Country
CH
Open
$3.18
Prev. Close
$3.17
Day Low
$3.02
Day High
$3.18
52W Low
$2.55
52W High
$4.98
Market Cap
$0.39B
Volume
1.05M
| 188,407 |
| $3.75 |
| 2 Apr 2026 | Redmile Group, LLC | 10 percent owner | S-Sale | Disposed | 169,265 | $3.80 |
| 2 Apr 2026 | Redmile Group, LLC | 10 percent owner | S-Sale | Disposed | 162,517 | $3.80 |
| 2 Apr 2026 | Redmile Group, LLC | 10 percent owner | S-Sale | Disposed | 2,634,506 | $3.28 |
| 2 Apr 2026 | Redmile Group, LLC | 10 percent owner | S-Sale | Disposed | 2,529,491 | $3.28 |
| 18 Feb 2026 | Kallebo Lisa Michelle | Chief Accounting Officer | F-InKind | Disposed | 5,433 | $3.99 |
| 18 Feb 2026 | Kallebo Lisa Michelle | Chief Accounting Officer | A-Award | Acquired | 62,900 | $3.99 |
| 18 Feb 2026 | Zaki Mohamed | Chief Medical Officer | F-InKind | Disposed | 24,603 | $3.99 |
| 18 Feb 2026 | Zaki Mohamed | Chief Medical Officer | A-Award | Acquired | 285,200 | $3.99 |